Part of the global pharmaceutical UBI Group, UBI Pharma consolidates the Group’s established values and builds a strong foundation of technology and production in the manufacture of pharmaceuticals, providing world-class pharmaceutical quality products. We develop innovative products such as non-monoclonal antibodies, novel small molecule drugs, and specialty injectables.
Pharmaceutical Manufacturing Center
Senior Vice President
Frank Wu is currently the Senior Vice President of the Pharmaceutical Business Center at UBI Pharma. He joined the UBI Group in 2001, and has led teams of professionals in the management of our cGMP-compliant manufacturing facility, which thanks to his efforts, has successfully passed the PIC/S GMP and the U.S. FDA inspections. With more than 30 years of experience in the pharmaceutical industry, Senior Deputy General Manager Mr. Wu is a frequently invited speaker at many pharmaceutical conferences due to his extensive expertise and experience in pharmaceutical production and management. Prior to joining UBI Pharma, Mr. Wu served as the Production Manager and Technical Support Manager at GSK Taiwan, and was later promoted to Technical Director. With his rich experience in production and technical development, he strengthened GSK’s production and R&D platforms in Taiwan. Mr. Wu also served at the Parke-Davis Corporation and Warner-Lambert (now Pfizer Inc.) as Production Manager, and thus developed extensive knowledge in production management and staffing. He also served as the Director of Vaccine Production Management for Taiwan Baosheng Vaccine Company, a collaborative partner of Sanofi-Pasteur in France for hepatitis B vaccines in Taiwan. Mr. Wu received his Bachelor of Pharmacy from Kaohsiung Medical University, specializing in pharmacology.